Log In
BCIQ
Print this Print this
 

H102

  Manage Alerts
Collapse Summary General Information
Company Shanghai Sunway Biotech Co. Ltd.
DescriptionRecombinant adenovirus which targets hepatocellular carcinoma (HCC) cells with alpha fetoprotein (AFP) over-expression
Molecular Target Alpha fetoprotein (AFP)
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular cancer (HCC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today